Medicare billing address
CMS Medicare provider billing file
6655 Post RdDublin, OH 43016
CMS public data · NPI 1487698288
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Louis J Chorich, MD
Specialty
Credential
MD
NPI
1487698288
Primary source state
OH
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Louis J Chorich, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
6655 Post RdCMS Doctors & Clinicians file
1355 Yauger RdCMS Doctors & Clinicians file
1550 London AveCMS Doctors & Clinicians file
2935 Maple AveIn the 2024 CMS provider billing file, this NPI had 1,023 Medicare beneficiaries and 39,930 total services. The average beneficiary age was 77, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$3,824,658.57
Total Medicare payment amount
$3,011,956.38
Medicare beneficiaries
1,023
Total services
39,930
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Ischemic heart disease
29%
CMS beneficiary-panel share
Mood disorders
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 24,840 | $34.59 |
| Injection, avacincaptad pegol, 0.1 mg | 3,720 | $108.61 |
| Injection, aflibercept hd, 1 mg | 3,152 | $327.77 |
| Imaging of retina | 2,721 | $39.15 |
| Injection of drug into eye | 1,796 | $115.38 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,267 | $126.05 |
| Injection, aflibercept, 1 mg | 858 | $830.11 |
| Unclassified biologics | 425 | $329.35 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 382 | $89.56 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 197 | $164.27 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1487698288. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisolone Acetate | Prednisolone Acetate | 119 | 194 | $3,238.51 |
| 2 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 81 | 81 | $723.09 |
| 3 | Atropine Sulfate | Atropine Sulfate | 58 | 117.7 | $1,634.86 |
| 4 | Timolol Maleate | Timolol Maleate | 40 | 68 | $235.40 |
| 5 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 35 | 77.4 | $744.71 |
| 6 | Difluprednate | Difluprednate | 31 | 37.5 | $2,908.40 |
| 7 | Brimonidine Tartrate | Brimonidine Tartrate | 29 | 39.9 | $139.14 |
| 8 | Latanoprost | Latanoprost | 23 | 46.1 | $195.82 |
| 9 | Ketorolac Tromethamine | Ketorolac Tromethamine | 18 | 30.3 | $222.08 |
| 10 | Dorzolamide Hcl | Dorzolamide Hcl | 16 | 18.3 | $120.78 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Ohio State University College Of Medicine
Graduation year
1992
Group/practice field
Midwest Retina, Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.